Valuing the Invisible: A Sectorial Analysis of Intangible assets in India's Information Technology and Pharmaceutical Industries

Srishti Gandhi1*, Dr. Mohit Jain2

[1] Research Scholar, Department of Accountancy and Business Statistics, ABST, University of Rajasthan, Jaipur, Rajasthan, India

yashikagandhi111@gmail.com

2 Assistant Professor, Department of Accountancy and Business Statistics, ABST, University of Rajasthan, Jaipur, Rajasthan, India

Abstract: In the era of knowledge-driven economies, intangible assets have emerged as pivotal contributors to organizational value and competitive advantage. This research paper undertakes a comparative sectoral study of intangible assets in India’s Information Technology (IT) and Pharmaceutical sectors—two of the most innovation-intensive and globally competitive industries. The study explores the classification, strategic importance, and financial impact of intangible assets such as intellectual property, proprietary software, patents, R&D outputs, human capital, and brand equity. Through detailed case studies of leading Indian companies, this paper analyzes sector-specific approaches to asset creation, protection, and valuation. Furthermore, it evaluates legal frameworks, accounting standards (Ind AS 38, IFRS IAS 38), and policy implications associated with intangible asset reporting. The findings underscore the need for enhanced disclosure practices, regulatory reform, and strategic IP management. The paper concludes with actionable recommendations for stakeholders and outlines avenues for future interdisciplinary research. This study contributes to academic and industry discourse by offering insights into how intangible assets shape sustainable business models and national economic resilience.

Keywords: Intangible assets, Information Technology, Pharmaceutical Industries

1. INTRODUCTION

In the modern business landscape, intangible assets have increasingly become a cornerstone of company value, particularly in sectors driven by innovation and intellectual capital. This study examines the role and significance of intangible assets within the Indian Information Technology (IT) and Pharmaceutical sectors. As these sectors represent high-growth areas in the Indian economy, understanding the management, valuation, and strategic importance of intangible assets is critical for business leaders, investors, and policymakers alike.

The Indian IT sector has seen exponential growth in recent decades, with companies like TCS, Infosys, and Wipro emerging as global players. Similarly, the pharmaceutical sector, with giants like Sun Pharma, Cipla, and Dr. Reddy’s, is not only integral to the national economy but also plays a key role in the global healthcare landscape. Both sectors rely heavily on intangible assets such as intellectual property, R&D outputs, brand equity, and organizational knowledge to drive business performance and innovation.

Intangible assets are non-physical assets that have significant economic value. They include intellectual property (IP), goodwill, patents, trademarks, software, and more. With a growing reliance on intellectual capital, these assets are crucial for differentiation, customer loyalty, and competitive positioning. This paper aims to explore how intangible assets contribute to the growth and strategic sustainability of companies in the IT and pharmaceutical sectors.

Background of the Study

In today’s rapidly evolving global economy, the primary drivers of value creation have shifted from physical and financial capital to knowledge-based and intangible resources. The emergence of the digital economy, coupled with globalization and technological innovation, has drastically changed how businesses operate and generate wealth. In such a context, intangible assets like intellectual property, brand equity, software, and human capital have emerged as vital components of corporate value.

India, as a growing economic power with a strong presence in sectors such as Information Technology (IT) and Pharmaceuticals, provides a rich landscape for exploring the strategic importance of intangible assets. These sectors are inherently innovation-driven and rely heavily on intellectual capital, research and development (R&D), and proprietary knowledge, making them ideal for a sector-specific study.

Importance of Intangible Assets in the 21^st Century Economy In the knowledge-based economy of the 21st century, intangible assets have become critical for sustainable growth, competitive advantage, and investor confidence. Companies with strong intangible asset portfolios are more resilient, agile, and likely to attract capital investment. Globally, firms like Apple, Microsoft, and Alphabet have demonstrated that the bulk of their value resides in intangible assets. Similarly, Indian firms in the IT and pharmaceutical sectors showcase significant investments in patents, software, trademarks, and skilled human resources.

Justification for Selecting IT and Pharmaceutical Sectors The IT and Pharmaceutical sectors are among the most prominent and rapidly growing industries in India. They are characterized by high innovation intensity, dependency on skilled labor, and continuous R&D investment.

· The IT sector leverages intangible assets such as software codes, algorithms, proprietary systems, and customer databases to deliver value.

· The pharmaceutical sector is driven by research, drug discovery, patents, and regulatory approvals, all of which are intangible by nature.

Analyzing these sectors provides insights into how intangible assets contribute to sectoral growth, innovation, and global competitiveness.

2. MEANING OF INTANGIBLE ASSETS

Definition and Conceptual Understanding

Intangible assets are identifiable non-monetary assets without physical substance. According to the International Financial Reporting Standards (IFRS), an intangible asset is an identifiable resource controlled by an entity from which future economic benefits are expected to flow. Indian Accounting Standard (Ind AS) 38 similarly defines intangible assets and provides guidelines for their recognition and measurement.

Intangible assets are non-physical assets that contribute to a company's long-term value. They encompass intellectual property (IP), goodwill, patents, trademarks, copyrights, brand names, software, and organizational knowledge. Unlike tangible assets such as machinery or land, intangible assets are not physically measurable but can significantly impact a company’s ability to generate future revenue and profits.

In accounting terms, intangible assets are categorized according to their nature and use. For instance, intellectual property (IP) includes patents, trademarks, copyrights, and trade secrets. Goodwill refers to the reputation and customer loyalty a company builds over time. Software and brand equity are examples of intangible assets that contribute directly to business growth and market leadership.

Types of Intangible Assets

· Intellectual Property Rights (IPRs): Patents, copyrights, trademarks, and industrial designs.

· Goodwill: Arising from business combinations and brand reputation.

· Software: Proprietary codes, applications, and platforms.

· Trade Secrets: Proprietary processes and formulations.

· Licenses and Franchises: Rights to use technologies or brand names.

Accounting and Valuation Standards

Ind AS 38 governs the accounting treatment of intangible assets in India. It lays down the criteria for recognition (identifiability, control, future economic benefits) and methods for subsequent measurement (cost model and revaluation model). Internationally, IFRS standards provide similar frameworks.

Tangible vs. Intangible Assets: A Comparative Analysis

Tangible assets include physical resources like machinery, buildings, and inventory. While they are easier to measure and value, they may depreciate over time. Intangible assets, although more complex to evaluate, often provide long-term strategic advantages and generate higher returns, especially in innovation-driven industries.

Legal and Regulatory Framework in India for Intangible Assets

India has developed a comprehensive legal regime to protect intangible assets:

· The Patents Act, 1970 (amended in 2005)

· The Trade Marks Act, 1999

· The Copyright Act, 1957

· The Designs Act, 2000

· The Information Technology Act, 2000 (for software and digital assets)

Challenges in Identification and Valuation

· Lack of standardized valuation methods: Infosys has developed multiple proprietary software platforms and customer databases. These software tools contribute to their service offerings and customer loyalty. However, there is no universally accepted method to value such intangible assets. For example, some industry experts may value the software based on its development cost, while others might rely on future revenue projections from the platform's use. The lack of a standardized approach complicates the accurate reporting of these assets, and the valuation might vary significantly depending on the method used.

· Difficulty in estimating future economic benefits: Estimating the future economic benefits of Infosys's intangible assets is difficult. For example, the future revenue generated from a specific software developed by Infosys depends on various factors such as market demand, customer retention, and technological advancements. Predicting how these elements will evolve over time is inherently uncertain, making it challenging for the company to determine the full value of its intangible assets.

· Ambiguities in legal ownership and control: Infosys may have multiple products and software developed collaboratively with clients or other technology firms. This raises issues around the legal ownership and control of these assets. If there is ambiguity in the contract or licensing agreements, determining who owns the rights to these intangibles becomes complex. For example, a software developed for a client could have joint ownership rights, making it difficult for Infosys to assess its share of the asset value.

· Limited disclosure in financial statements: Infosys, like many other IT companies, may underreport the true value of its intangible assets in financial statements. This is often due to regulatory requirements that limit the disclosure of internal proprietary technologies, customer databases, and brand value. In India, under the Indian Accounting Standards (Ind AS 38), intangible assets are often disclosed only when they have a clear cost base or measurable value, leaving out many unreported intangibles like human capital, organizational knowledge, and market positioning. As a result, stakeholders might not fully understand the true economic potential of Infosys’s intangible assets.

3. ROLE OF INTANGIBLE ASSETS IN BUSINESS GROWTH

3.1 In the Information Technology Sector

Nature of Intangible Assets in IT

IT companies heavily invest in software, proprietary algorithms, databases, and digital platforms. Human capital, organizational culture, and client relationships also form significant intangible assets.

In the Information Technology (IT) sector, intangible assets form the backbone of business operations and growth. These include proprietary software, intellectual property (IP), customer relationships, algorithms, and organizational knowledge. Companies like TCS, Infosys, and Wipro rely heavily on their software and technological innovations to provide high-value services to clients worldwide.

Case Studies of Major Indian IT Companies

· TCS: Invests significantly in platforms like Ignio and MasterCraft.

· Infosys: Focuses on knowledge management, digital platforms, and design thinking.

· Wipro: Develops proprietary software and has a strong intellectual property strategy.

One of the primary intangible assets in the IT sector is software. For instance, custom-developed software platforms, cloud-based solutions, and proprietary tools enable IT companies to deliver scalable solutions to diverse industries. Additionally, IP such as software patents, algorithms, and source code further enhances their technological edge and marketability.

R&D and Innovation as Value Drivers Continuous innovation through R&D is essential for maintaining competitiveness. Many IT firms invest in in-house research labs and collaborate with academia and startups.

Role of Human Capital and Organizational Knowledge Employees' skills, experience, and tacit knowledge are invaluable assets. Companies implement training programs and knowledge management systems to retain and grow these assets.

Branding and Market Positioning Brand equity, customer trust, and global certifications enhance the perceived value of Indian IT firms and drive international contracts.

Furthermore, the knowledge embedded in human capital from technical experts to project managers is invaluable in maintaining a competitive advantage. R&D activities, including innovation in software development and artificial intelligence, contribute significantly to the development of intangible assets in the IT sector.

3.2 In the Pharmaceutical Sector

Nature of Intangible Assets in Pharma

The pharmaceutical industry, intangible assets such as patents, drug formulations, clinical data, and regulatory approvals play a crucial role in driving innovation, market positioning, and long-term profitability. The ability to secure patents for new drugs and treatments creates significant barriers to entry and enhances revenue-generating capacity through product exclusivity.

Case Studies of Major Indian Pharmaceutical Companies

· Sun Pharma: Invests in complex generics and specialty drugs.

· Dr. Reddy’s: Focuses on biosimilars and active pharmaceutical ingredients (APIs).

· Cipla: Known for respiratory and HIV medications, leveraging strong R&D capabilities.

Pharmaceutical companies like Sun Pharma and Dr. Reddy’s leverage their extensive R&D activities to generate intellectual property that is critical for new drug development. Patents and regulatory exclusivity give these companies a competitive edge, allowing them to maintain a monopoly on their products in key markets for several years. In addition, clinical trial data, which is often proprietary, provides companies with valuable information to bring new drugs to market.

The role of brand equity cannot be understated in the pharmaceutical sector either. Brands associated with quality, innovation, and trust are essential for attracting customers and retaining loyalty, both in domestic and international markets.

R&D Intensity and Patent Strategies

Pharma firms invest heavily in R&D to develop new molecules and obtain patents. The process is lengthy and expensive but yields high returns if successful.

Role of Regulatory Approvals and Product Exclusivity

Approvals from bodies like the US FDA, EMA, and DCGI enhance credibility and provide market exclusivity, acting as key intangible assets.

International Collaborations and Licensing

Licensing agreements, co-marketing deals, and technology transfers are common and help in expanding global reach.

3.3 Comparative Sectoral Analysis

Intangible Asset Intensity: IT vs. Pharma

While both sectors rely heavily on intangibles, IT focuses more on human capital and software, whereas pharma emphasizes patents and clinical research.

Market Valuation and Investor Perspective Intangible-rich companies often have higher market valuations. Investors view R&D pipelines and brand equity as indicators of long-term value.

Sector-specific Challenges in Managing Intangibles

· IT: Rapid tech obsolescence, employee attrition

· Pharma: High regulatory risks, long R&D cycles

IP Protection and Enforcement Mechanisms India has improved its IP regime but enforcement remains a concern, especially in combating piracy, counterfeiting, and data theft.

While both the IT and pharmaceutical sectors rely on intangible assets, the specific types of intangibles vary significantly. In the IT sector, the focus is on software, algorithms, and human capital, while in the pharmaceutical sector, patents, regulatory exclusivity, and R&D outputs take precedence. Both sectors, however, share common challenges in managing and valuing these assets.

Intangible assets in the IT sector are often more dynamic and constantly evolving, with new technologies emerging rapidly. In contrast, intangible assets in the pharmaceutical industry tend to have longer lifecycles, often protected by patents for extended periods. In both sectors, IP protection and enforcement mechanisms play a crucial role in maintaining competitive advantages.

4. CONCLUSION

Summary of Key Findings

This sectoral study underscores that intangible assets are not auxiliary but foundational to value creation and competitive sustainability in both the IT and pharmaceutical sectors. These assets play a pivotal role in product differentiation, customer engagement, innovation, and global market reach. Companies that recognize, quantify, and manage these assets strategically exhibit improved financial performance, agility in responding to market dynamics, and superior stakeholder trust. The study confirms a strong correlation between intangible asset stewardship and long-term business resilience.

सर्वं ज्ञानमयं जगत्। Sarvaṁ jñānamayaṁ jagat — The entire universe is pervaded by knowledge. This underscores that knowledge is not just power but a vital form of wealth — aligning with the central role of intangible assets like intellectual capital.

Sector-wise Insights on the Strategic Importance of Intangibles

· IT Sector: The IT industry thrives on intellectual agility, with organizational knowledge, software development, and human capital forming its intangible backbone. Companies like TCS and Infosys leverage proprietary software platforms and strategic knowledge initiatives to lead in digital innovation. Brand equity further amplifies global visibility and client retention.

· Pharmaceutical Sector: Here, the focus is on R&D excellence, patent acquisition, and regulatory approvals, which create high-entry barriers and revenue exclusivity. Firms such as Sun Pharma and Dr. Reddy’s capitalize on global IP filings and clinical innovations to secure market leadership. The sector's intangible assets have a direct impact on export capacity and international licensing revenue.

Policy Implications for Indian Companies and Regulators

Develop and Enforce Comprehensive Valuation Models that Capture the Economic Value of Intangibles

To address the challenges in valuing intangible assets, Indian regulators must design a comprehensive framework that incorporates universally recognized valuation methodologies. This could include:

· Establishing a Standardized Framework: The government should collaborate with accounting bodies like the Institute of Chartered Accountants of India (ICAI) to develop a standardized approach for valuing intangible assets. This framework would provide companies with clear guidelines on how to value intangible assets such as intellectual property, customer relationships, and proprietary technologies.

· Valuation Based on Future Economic Benefits: Regulators should guide the use of future economic benefit models, such as income-based or market-based approaches, to value intangible assets. These models would allow companies to estimate future revenues, profits, or cost savings generated by their intangible assets.

· Incentivize Independent Valuation Services: Encouraging third-party evaluations from certified professionals would provide an unbiased perspective on the value of intangible assets, ensuring transparency and improving investor confidence.

Create Sector-Specific Accounting Standards and Disclosure Mandates Aligned with Global Best Practices

Indian regulators must create and implement accounting standards that specifically address the unique characteristics of intangible assets in different sectors:

· Tailored Accounting Standards: Similar to the International Financial Reporting Standards (IFRS), Indian regulators could develop sector-specific standards that focus on how intangible assets should be recognized, measured, and disclosed for industries like IT, pharmaceuticals, and manufacturing. For example, the pharmaceutical industry could have guidelines for valuing R&D expenses, patents, and clinical trial data, while the IT sector could have guidelines for software and proprietary algorithms.

· Mandatory Disclosure: Establishing clear disclosure requirements under Indian Accounting Standards (Ind AS 38) would ensure companies provide adequate details about the nature and value of intangible assets. This would enhance the transparency of financial statements and allow investors to assess the true worth of companies.

· Adoption of Global Best Practices: India should align its regulations with global standards such as the IFRS and US GAAP to ensure that Indian companies are competitive on the international stage and that their financial reports are comparable to global peers.

Encourage Innovation through Tax Credits, Patent Subsidies, and State-Supported R&D Incubation Programs

To drive innovation and foster the growth of intangible assets, the government can take several proactive steps:

· Tax Credits for R&D Investments: The Indian government can offer tax credits or deductions to companies investing in research and development (R&D). This would incentivize businesses to allocate more resources toward developing innovative products, technologies, and intellectual property.

· Patent Subsidies: The government can introduce patent subsidies or grants to help companies protect their innovations. This could include a reduction in the costs associated with filing patents or providing financial support for patent litigation, making it easier for smaller companies and startups to secure intellectual property rights.

· State-Supported R&D Incubators: Establishing R&D incubation centers backed by the government would provide startups and emerging companies with the resources and infrastructure needed to innovate. These centers could offer access to funding, mentorship, lab spaces, and collaborations with universities, helping companies translate research into tangible intellectual property.

· Public-Private Partnerships: The government could create public-private partnerships (PPP) to fund high-risk, high-reward research projects. These collaborations could help foster the development of new technologies that could become valuable intangible assets in the future.

Streamline IP Dispute Resolution by Establishing Specialized IPR Benches and Adopting Digital Litigation Tools

To improve the efficiency of intellectual property (IP) dispute resolution, India could undertake the following steps:

· Specialized IPR Benches: The creation of dedicated IPR benches within the judiciary would ensure that intellectual property disputes are handled by judges with specialized knowledge and experience. These courts could streamline the process, reducing the time taken to resolve IP conflicts, which is crucial for companies relying on their intellectual property assets.

· Expedited Procedures: The establishment of fast-track mechanisms for certain types of IP disputes, such as patent infringement cases or trade secret theft, could significantly speed up the resolution process.

· Adoption of Digital Litigation Tools: The government can modernize the IP dispute resolution process by adopting digital tools for filing, tracking, and resolving cases. This could include setting up an online platform where companies can easily file complaints, track the status of their cases, and engage in virtual hearings. The introduction of blockchain for tracking patent ownership and infringement could also ensure transparency and prevent fraudulent activities.

· Alternative Dispute Resolution (ADR) Mechanisms: Encouraging companies to resolve IP conflicts through mediation and arbitration rather than going through lengthy court procedures can reduce the burden on the judicial system and lead to quicker, mutually agreeable outcomes. ADR could be encouraged with the backing of legal professionals skilled in IP law.

These measures would significantly improve the regulatory framework for intangible assets in India, boosting innovation, protecting intellectual property, and ensuring that companies can effectively manage and capitalize on their intangible assets. By aligning with global best practices, Indian companies would be better positioned in the competitive global market.

References

1. Indian Accounting Standard (Ind AS) 38 - Intangible Assets. Defines recognition, measurement, and disclosure of intangibles in India.

2. International Financial Reporting Standards (IFRS) – IAS 38. International standard governing intangible asset reporting.

3. World Intellectual Property Organization (WIPO) Reports (2023). Provides global statistics and IP trends.

4. Ministry of Electronics & IT, Government of India. Publishes reports on India’s IT infrastructure and innovation.

5. Indian Patent Office – Annual Report (2022). Details national patent filings and sectoral IP trends.

6. Nasscom Reports on Indian IT Industry (2023). Covers growth drivers, employment, and intangible strength in IT.

7. CII-KPMG Report on Pharmaceutical Sector (2023). Analyzes investment in innovation and IP strategies.

8. EY Global Intangible Assets Study (2022). Provides insights into corporate valuation practices globally.

9. Deloitte Insights – Valuation of Intangible Assets (2022). Explores methodologies for valuing intangible assets.

10. McKinsey & Company – Role of Innovation in Emerging Markets (2023). Links intangible investment with market growth.

11. Harvard Business Review – Managing Intellectual Capital (2021). Discusses strategies for leveraging knowledge assets.

12. Financial Express, “India’s Pharma Growth Driven by R&D” (2022). Analyzes pharmaceutical innovation in India.

13. Economic Times, “Brand Value in India’s IT Giants” (2023). Evaluates brand-driven growth strategies in IT.

14. Journal of Intellectual Property Rights (CSIR-NISCAIR). Publishes scholarly articles on IP law and policy.

15. OECD – Enhancing the Value of Intangibles in Business (2021). Offers global benchmarks for IP-driven development.